COEP
Coeptis Therapeutics Inc
NASDAQ: COEP · HEALTHCARE · BIOTECHNOLOGY
$16.40
+1.17% today
Updated 2026-04-24
Market cap
$102.06M
P/E ratio
—
P/S ratio
74.88x
EPS (TTM)
$-2.81
Dividend yield
—
52W range
$7 – $21
Volume
0.0M
Coeptis Therapeutics Inc (COEP) Financial statements
SEC filings — annual and quarterly data.
Profit margin
0.00%
Operating margin
-230.70%
ROE
-136.90%
ROA
-65.10%
Debt/equity
—
Margin trends — annual
Gross margin Operating margin Profit margin
| Year | Revenue | Net income | Gross margin | Op. margin | Profit margin |
|---|---|---|---|---|---|
| 2004 | — | $2.65M | — | — | — |
| 2005 | — | $-344000.00 | — | — | — |
| 2018 | — | $-7073.00 | — | — | — |
| 2019 | — | $-2234.00 | — | — | — |
| 2020 | $30761.00 | $-9.16M | -3,034.54% | -22,305.53% | -29,765.89% |
| 2021 | $75000.00 | $-13.45M | 100.00% | -18,727.91% | -17,932.37% |
| 2022 | $0.00 | $-37.57M | — | — | — |
| 2023 | $0.00 | $-21.27M | — | — | — |
| 2024 | $0.00 | $-10.88M | — | — | — |
| 2025 | $1.36M | $-11.92M | -207.81% | -956.94% | -874.29% |